Modification of Estrogenic Effect of Nonylphenol Combined with DEHP in Yeast-based Bioassay

형질전환효모를 이용한 내분비계장애물질검색과 Nonylphenol의 Estrogen 유사작용에 대한 DEHP의 상협작용

  • 박미선 (식품의약품안전청, 국립독성연구소 독성부) ;
  • 정해관 (식품의약품안전청, 국립독성연구소 독성부) ;
  • 박현신 (식품의약품안전청, 국립독성연구소 독성부) ;
  • 한의식 (식품의약품안전청, 국립독성연구소 독성부) ;
  • 김종원 (식품의약품안전청, 국립독성연구소 독성부) ;
  • 엄미옥 (식품의약품안전청, 국립독성연구소 독성부) ;
  • 정상희 (국립수의과학연구소) ;
  • 오혜영 (식품의약품안전청, 국립독성연구소 독성부)
  • Published : 2001.03.01

Abstract

The key targets of endocrine disruptors are nuclear hormone receptors, which bind to steroid hormones and regulate their gene transcription. A yeast-based steroid hormone receptor gene trascription assay was previously developed for the evaluation of chemicals with endocrine modulating activity. The yeast transformants used in this assay contain the human estrogen receptor along with the appropriate steroid response elements upstream of the $\beta$-galactosidase reporter gene. We tried to evaluate several natural and synthetic steroids of their potential to interact directly with the steroid receptor. Some putative endocrine disruptors, including nonylphenol, are weakly estrogenic. But the combined treatment oj these chemicals with di-(2-ethylhexyl)phthalate (DEHP) significantly increased the $\beta$-galactosidase activity in the yeast transformant. These results suggest that we also have to consider the synergistic effects of endocrine disruptors. In this study, we showed that yeast-based bioassay is a valuable tool for screening potential endocrine disruptors and quantitative determination of estrogenicity. And the possibility that the estrogen receptor binds multiple environmental chemicals adds another level of complexity to the interaction between the endocrine disruptors and the human hormone system.

Keywords